Tudor Investment Corp’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249K | Sell |
4,674
-40,327
| -90% | -$2.15M | ﹤0.01% | 1415 |
|
|
2025
Q1 | $1.82M | Buy |
45,001
+10,207
| +29% | +$413K | 0.01% | 840 |
|
|
2024
Q4 | $968K | Buy |
34,794
+160
| +0.5% | +$4.45K | ﹤0.01% | 1021 |
|
|
2024
Q3 | $994K | Buy |
34,634
+315
| +0.9% | +$9.04K | ﹤0.01% | 1007 |
|
|
2024
Q2 | $805K | Sell |
34,319
-1,876
| -5% | -$44K | ﹤0.01% | 1050 |
|
|
2024
Q1 | $914K | Buy |
+36,195
| New | +$914K | 0.01% | 914 |
|
|
2023
Q4 | – | Sell |
-31,881
| Closed | -$1.61M | – | 1439 |
|
|
2023
Q3 | $1.61M | Buy |
+31,881
| New | +$1.61M | 0.02% | 731 |
|
|
2023
Q2 | – | Sell |
-36,885
| Closed | -$1.41M | – | 1499 |
|
|
2023
Q1 | $1.41M | Buy |
36,885
+13,887
| +60% | +$531K | 0.02% | 770 |
|
|
2022
Q4 | $1.26M | Buy |
22,998
+10,852
| +89% | +$595K | 0.02% | 747 |
|
|
2022
Q3 | $414K | Buy |
+12,146
| New | +$414K | 0.01% | 1172 |
|